164 related articles for article (PubMed ID: 34393999)
1. Seminal Plasma Lipidomics Profiling to Identify Signatures of Kallmann Syndrome.
Li X; Wang X; Li H; Li Y; Guo Y
Front Endocrinol (Lausanne); 2021; 12():692690. PubMed ID: 34393999
[TBL] [Abstract][Full Text] [Related]
2. Seminal plasma metabolomics and lipidomics profiling to identify signatures of pituitary stalk interruption syndrome.
Guo Y; Li X; Wang X; Li H; Luo G; Si Y; Wu X; Li Y
Orphanet J Rare Dis; 2022 Jul; 17(1):267. PubMed ID: 35841106
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic alterations associated with Kallmann syndrome.
Guo Y; Li X; Yan S; Li Y
Ann Transl Med; 2020 Apr; 8(8):529. PubMed ID: 32411752
[TBL] [Abstract][Full Text] [Related]
4. Lipid profiling in malignant mesothelioma reveals promising signatures for diagnosis and prognosis: A plasma-based LC-MS lipidomics study.
Chen Z; Song S; Yang C; Dai Z; Gao Y; Li N; Zhu J; Mao W; Liu J
Clin Chim Acta; 2022 Jan; 524():34-42. PubMed ID: 34843704
[TBL] [Abstract][Full Text] [Related]
5. Discovery of lipid profiles of type 2 diabetes associated with hyperlipidemia using untargeted UPLC Q-TOF/MS-based lipidomics approach.
Yan L; Han P; Man J; Tian Y; Wang F; Wang J
Clin Chim Acta; 2021 Sep; 520():53-62. PubMed ID: 34077755
[TBL] [Abstract][Full Text] [Related]
6. High resolution mass spectrometry coupled with multivariate data analysis revealing plasma lipidomic alteration in ovarian cancer in Asian women.
Zhang Y; Liu Y; Li L; Wei J; Xiong S; Zhao Z
Talanta; 2016 Apr; 150():88-96. PubMed ID: 26838385
[TBL] [Abstract][Full Text] [Related]
7. Seminal plasma metabolomics signatures of normosmic congenital hypogonadotropic hypogonadism.
Li X; Guo Y; Wang X; Li H; Mao J; Yan S; Luo G; Wang R; Wu X; Li Y
Heliyon; 2023 Apr; 9(4):e14779. PubMed ID: 37025907
[TBL] [Abstract][Full Text] [Related]
8. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma.
Choi JM; Kim TE; Cho JY; Lee HJ; Jung BH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():157-65. PubMed ID: 24316528
[TBL] [Abstract][Full Text] [Related]
9. Lipidomics random forest algorithm of seminal plasma is a promising method for enhancing the diagnosis of necrozoospermia.
Deng T; Wang W; Fu Z; Xie Y; Zhou Y; Pu J; Chen K; Yao B; Li X; Yao J
Metabolomics; 2024 May; 20(3):57. PubMed ID: 38773045
[TBL] [Abstract][Full Text] [Related]
10. Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats.
Yang F; Liu M; Qin N; Li S; Yu M; Wang C; Ma Q
Lipids Health Dis; 2019 May; 18(1):112. PubMed ID: 31077208
[TBL] [Abstract][Full Text] [Related]
11. [Nontargeted lipidomic analysis of sera from sepsis patients based on ultra-high performance liquid chromatography-mass spectrometry/mass spectrometry].
Wang S; Liang J; Shi H; Xia Y; Li J; Wu W; Wang H; Wu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):346-351. PubMed ID: 35692196
[TBL] [Abstract][Full Text] [Related]
12. Revealing the role of glycerophospholipid metabolism in asthma through plasma lipidomics.
Wang S; Tang K; Lu Y; Tian Z; Huang Z; Wang M; Zhao J; Xie J
Clin Chim Acta; 2021 Feb; 513():34-42. PubMed ID: 33307061
[TBL] [Abstract][Full Text] [Related]
13. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic alterations associated with Behçet's disease.
Zheng W; Wu X; Goudarzi M; Shi J; Song W; Li C; Liu J; Chen H; Zhang X; Zeng X; Li HH
Arthritis Res Ther; 2018 Sep; 20(1):214. PubMed ID: 30249301
[TBL] [Abstract][Full Text] [Related]
15. UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis.
Guan S; Jia B; Chao K; Zhu X; Tang J; Li M; Wu L; Xing L; Liu K; Zhang L; Wang X; Gao X; Huang M
J Proteome Res; 2020 Feb; 19(2):600-609. PubMed ID: 31821004
[TBL] [Abstract][Full Text] [Related]
16. UPLC-MS based plasma metabolomics and lipidomics reveal alterations associated with IgG4-related disease.
Gong Y; Zhang P; Liu Z; Li J; Lu H; Wang Y; Qiu B; Wang M; Fei Y; Chen H; Peng L; Li J; Zhou J; Shi Q; Zhang X; Shen M; Zeng X; Zhang F; Zhang W
Rheumatology (Oxford); 2021 Jul; 60(7):3252-3261. PubMed ID: 33341881
[TBL] [Abstract][Full Text] [Related]
17. UPLC-MS/MS-based plasma lipidomics reveal a distinctive signature in systemic lupus erythematosus patients.
Chen J; Liu C; Ye S; Lu R; Zhu H; Xu J
MedComm (2020); 2021 Jun; 2(2):269-278. PubMed ID: 34766146
[TBL] [Abstract][Full Text] [Related]
18. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
[TBL] [Abstract][Full Text] [Related]
19. Ultraperformance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics and Lipidomics Identify Biomarkers for Efficacy Evaluation of Mesalazine in a Dextran Sulfate Sodium-Induced Ulcerative Colitis Mouse Model.
Liu K; Jia B; Zhou L; Xing L; Wu L; Li Y; Lu J; Zhang L; Guan S
J Proteome Res; 2021 Feb; 20(2):1371-1381. PubMed ID: 33356298
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic and lipidomic assessment of the metabolic syndrome in Dutch middle-aged individuals reveals novel biological signatures separating health and disease.
Surowiec I; Noordam R; Bennett K; Beekman M; Slagboom PE; Lundstedt T; van Heemst D
Metabolomics; 2019 Feb; 15(2):23. PubMed ID: 30830468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
